- Home
- GXAI vs IMCC Comparison
GXAI vs IMCC Comparison
Compare GXAI & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GXAI | IMCC |
|---|---|---|
| Founded | 2021 | 1980 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8M | 10.4M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | GXAI | IMCC |
|---|---|---|
| Price | $1.24 | $1.78 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 107.7K | ★ 127.8K |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $694,278.00 | ★ $37,606,703.00 |
| Revenue This Year | N/A | $47.12 |
| Revenue Next Year | N/A | $12.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 23205.74 | 1.92 |
| 52 Week Low | $1.00 | $0.93 |
| 52 Week High | $7.50 | $7.12 |
Technical Indicators
Market Signals| Indicator | GXAI | IMCC |
|---|---|---|
| Relative Strength Index (RSI) | 40.79 | 56.25 |
| Support Level | $1.19 | $1.65 |
| Resistance Level | $1.29 | $1.84 |
| Average True Range (ATR) | 0.10 | 0.19 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 63.93 | 85.26 |
Price Performance
Historical ComparisonAbout GXAI Gaxos.ai Inc.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.